Another recent example of its efforts to boost personalized medicine is the Group’s investments to offer molecular genetics, cellular, and immunological profile testing in the UAE.

Source: https://mid-east.info/burjeel-medical-city-selected-to-join-the-worldwide-innovative-networking-in-personalized-cancer-medicine-win-consortium/

Establishing POBA will focus on validating the immunological effects associated with an anti-thymoglobulin mechanism of action in modulating autoimmune response associated with progression of T1D.

Source: https://forextv.com/top-news/sab-biotherapeutics-announces-commencement-of-the-human-phase-1-clinical-trial-with-sab-142-a-potential-disease-modifying-treatment-for-type-1-diabetes/

The totality of our clinical data set shows significant improvements in tumor response and overall survival, coupled with highly correlated immunological responses measured by an improved T cell profile in the tumor microenvironment.

Source: https://seekingalpha.com/article/4647464-oncolytics-biotech-inc-oncy-q3-2023-earnings-call-transcript?source=feed_all_articles

“Tools like webinars, podcasts and booklets can help to educate the wider community further on immunology and immunological disease.”

Source: https://www.siliconrepublic.com/innovation/immunology-disease-lara-dungan